NEWS

Recent News

NantKwest to Participate at Upcoming Investment Conferences

CULVER CITY, CALIFORNIA- May 15, 2019 - NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be participating in a number of investment conferences during the month of May...

NantKwest to Present at Upcoming Investment Conferences

CULVER CITY, CA - April 3, 2019 - NantKwest (Nasdaq:NK), a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be participating at a number of investment conferences during the month of April 2019....

NantKwest to Participate at World Immunotherapy Congress

CULVER CITY, CA – March 1, 2019 - NantKwest (Nasdaq:NK), a member of the NantWorks ecosystem of companies,  a leading clinical-stage, natural killer cell based therapeutics company, today announced that the company will be making two presentations at...

Archives

Media Contact:

Jen Hodson
NantKwest
Telephone: 562-397-3639
Email: Press@NantKwest.com